10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2015 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 19, 2016) | |||
(In Thousands, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] | |||
Net Cash Provided by Operating Activities [Abstract] | |||
Cash Flows from Operating Activities | |||
Net income | $ 2,408,400 | 2,390,500 | 4,684,800 |
Adjustments to Reconcile Net Income to Cash Flows from Operating Activities: | |||
Depreciation and amortization | 1,427,700 | 1,379,000 | 1,445,600 |
Change in deferred income taxes | (748,400) | 36,800 | 265,900 |
Stock-based compensation expense | 217,800 | 156,000 | 144,900 |
Acquired in-process research and development | 535,000 | 200,200 | 57,100 |
Income related to termination of the exenatide collaboration with Amylin | 0 | 0 | (495,400) |
Net proceeds from (payments for) terminations of interest rate swaps | (186,100) | 340,700 | 0 |
Other non-cash operating activities, net | 36,400 | 13,800 | 25,100 |
Other changes in operating assets and liabilities, net of acquisitions and divestitures: | |||
Receivables - (increase) decrease | (304,500) | 117,400 | (152,700) |
Inventories - (increase) decrease | (736,300) | (307,100) | (286,500) |
Other assets - (increase) decrease | (338,800) | 411,500 | 116,500 |
Accounts payable and other liabilties-increase (decrease) | 461,600 | (371,700) | (70,300) |
Net Cash Provided by Operating Activities | 2,772,800 | 4,367,100 | 5,735,000 |
Net Cash Provided By (Used In) Investing Activities [Abstract] | |||
Cash Flows from Investing Activities | |||
Purchases of property and equipment | (1,066,200) | (1,162,600) | (1,012,100) |
Disposals of property and equipment | 92,600 | 15,300 | 179,400 |
Cash released (restricted) for pending acquisition | 5,405,600 | (5,405,600) | 0 |
Proceeds from sales and maturities of short-term investments | 2,161,800 | 4,054,100 | 3,320,100 |
Purchases of short-term investments | (842,200) | (1,637,800) | (1,531,000) |
Proceeds from sales of noncurrent investments | 3,068,400 | 11,009,400 | 11,235,000 |
Purchases of noncurrent investments | (3,226,500) | (9,802,700) | (14,041,900) |
Proceeds from sale of product rights | 410,000 | 0 | 0 |
Purchase of product rights | 0 | (308,300) | (24,100) |
Purchases of in-process research and development | (560,000) | (95,000) | (57,100) |
Cash paid for acquisitions, net of cash acquired | (5,283,100) | (551,400) | (43,700) |
Other investing activities, net | (133,600) | (24,500) | (97,400) |
Net Cash Provided by (Used for) Investing Activities | 26,800 | (3,909,100) | (2,072,800) |
Net Cash Used in Financing Activities [Abstract] | |||
Cash Flows from Financing Activities | |||
Dividends paid | (2,127,300) | (2,101,200) | (2,120,700) |
Net change in short-term borrowings | (2,680,600) | 2,680,600 | 0 |
Proceeds from issuance of long-term debt | 4,454,700 | 992,900 | 0 |
Repayments of long-term debt | (1,955,700) | (1,034,800) | (10,500) |
Purchases of common stock | (749,500) | (800,000) | (1,698,100) |
Other financing activities, net | 139,200 | 187,400 | 0 |
Net Cash Used for Financing Activities | (2,919,200) | (75,100) | (3,829,300) |
Effect of exchange rate changes on cash and cash equivalents | (85,600) | (341,500) | (21,500) |
Net increase (decrease) in cash and cash equivalents | (205,200) | 41,400 | (188,600) |
Cash and cash equivalents at beginning of year | 3,871,600 | 3,830,200 | |
Cash and Cash Equivalents at End of Year | 3,666,400 | 3,871,600 | 3,830,200 |
External Links | |
ELI LILLY & CO (LLY) Fiscal Year 2015 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |